大塚ホールディングスの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2023/04/07 | 4,290 | 4,293 | 4,231 | 4,242 | -36 | -0.8% | 930,100 |
| 2023/04/06 | 4,247 | 4,283 | 4,216 | 4,278 | +54 | +1.3% | 1,660,400 |
| 2023/04/05 | 4,294 | 4,299 | 4,212 | 4,224 | -64 | -1.5% | 1,546,100 |
| 2023/04/04 | 4,217 | 4,296 | 4,207 | 4,288 | +73 | +1.7% | 1,585,600 |
| 2023/04/03 | 4,227 | 4,242 | 4,196 | 4,215 | +12 | +0.3% | 1,161,000 |
| 2023/03/31 | 4,202 | 4,219 | 4,185 | 4,203 | +7 | +0.2% | 1,807,800 |
| 2023/03/30 | 4,243 | 4,253 | 4,175 | 4,196 | -31 | -0.7% | 1,371,200 |
| 2023/03/29 | 4,166 | 4,229 | 4,145 | 4,227 | +87 | +2.1% | 2,289,300 |
| 2023/03/28 | 4,065 | 4,185 | 4,057 | 4,140 | +122 | +3% | 2,566,300 |
| 2023/03/27 | 3,999 | 4,030 | 3,979 | 4,018 | +51 | +1.3% | 1,228,900 |
| 2023/03/24 | 3,982 | 3,984 | 3,950 | 3,967 | ±0 | ±0% | 1,259,900 |
| 2023/03/23 | 3,935 | 3,973 | 3,920 | 3,967 | +9 | +0.2% | 1,431,500 |
| 2023/03/22 | 3,971 | 3,985 | 3,927 | 3,958 | +40 | +1% | 1,627,800 |
| 2023/03/20 | 3,978 | 3,991 | 3,914 | 3,918 | -73 | -1.8% | 1,091,800 |
| 2023/03/17 | 3,956 | 3,994 | 3,947 | 3,991 | +53 | +1.3% | 2,007,200 |
| 2023/03/16 | 3,922 | 3,947 | 3,913 | 3,938 | -35 | -0.9% | 1,651,200 |
| 2023/03/15 | 3,980 | 3,987 | 3,950 | 3,973 | +24 | +0.6% | 1,539,300 |
| 2023/03/14 | 3,955 | 3,964 | 3,891 | 3,949 | -60 | -1.5% | 2,038,700 |
| 2023/03/13 | 4,002 | 4,017 | 3,977 | 4,009 | -34 | -0.8% | 1,804,900 |
| 2023/03/10 | 4,044 | 4,068 | 4,032 | 4,043 | -35 | -0.9% | 2,416,400 |
| 2023/03/09 | 4,088 | 4,090 | 4,055 | 4,078 | +3 | +0.1% | 1,768,600 |
| 2023/03/08 | 4,060 | 4,082 | 4,042 | 4,075 | +37 | +0.9% | 2,542,600 |
| 2023/03/07 | 3,949 | 4,042 | 3,946 | 4,038 | +78 | +2% | 4,211,100 |
| 2023/03/06 | 3,979 | 3,983 | 3,928 | 3,960 | +17 | +0.4% | 4,553,900 |
| 2023/03/03 | 3,838 | 3,949 | 3,827 | 3,943 | -175 | -4.2% | 10,278,600 |
| 2023/03/02 | 4,143 | 4,155 | 4,102 | 4,118 | -4 | -0.1% | 892,000 |
| 2023/03/01 | 4,148 | 4,150 | 4,091 | 4,122 | -12 | -0.3% | 919,500 |
| 2023/02/28 | 4,131 | 4,147 | 4,119 | 4,134 | -12 | -0.3% | 1,644,300 |
| 2023/02/27 | 4,137 | 4,150 | 4,115 | 4,146 | +1 | ±0% | 849,700 |
| 2023/02/24 | 4,121 | 4,147 | 4,067 | 4,145 | +15 | +0.4% | 1,342,600 |
| 2023/02/22 | 4,162 | 4,177 | 4,098 | 4,130 | -39 | -0.9% | 1,495,800 |
| 2023/02/21 | 4,150 | 4,169 | 4,129 | 4,169 | +5 | +0.1% | 941,600 |
| 2023/02/20 | 4,209 | 4,219 | 4,159 | 4,164 | -11 | -0.3% | 1,017,300 |
| 2023/02/17 | 4,179 | 4,197 | 4,162 | 4,175 | -32 | -0.8% | 1,455,600 |
| 2023/02/16 | 4,200 | 4,216 | 4,167 | 4,207 | +9 | +0.2% | 1,080,800 |
| 2023/02/15 | 4,197 | 4,294 | 4,188 | 4,198 | +11 | +0.3% | 1,362,500 |
| 2023/02/14 | 4,153 | 4,255 | 4,130 | 4,187 | +87 | +2.1% | 1,373,600 |
| 2023/02/13 | 4,121 | 4,134 | 4,090 | 4,100 | -37 | -0.9% | 637,400 |
| 2023/02/10 | 4,174 | 4,178 | 4,112 | 4,137 | +5 | +0.1% | 1,010,500 |
| 2023/02/09 | 4,117 | 4,142 | 4,105 | 4,132 | ±0 | ±0% | 625,700 |
| 2023/02/08 | 4,121 | 4,155 | 4,108 | 4,132 | +44 | +1.1% | 718,100 |
| 2023/02/07 | 4,107 | 4,137 | 4,080 | 4,088 | -32 | -0.8% | 763,600 |
| 2023/02/06 | 4,130 | 4,137 | 4,106 | 4,120 | +33 | +0.8% | 765,500 |
| 2023/02/03 | 4,101 | 4,134 | 4,084 | 4,087 | -28 | -0.7% | 788,600 |
| 2023/02/02 | 4,130 | 4,134 | 4,107 | 4,115 | -38 | -0.9% | 544,900 |
| 2023/02/01 | 4,188 | 4,193 | 4,140 | 4,153 | -5 | -0.1% | 687,800 |
| 2023/01/31 | 4,190 | 4,200 | 4,154 | 4,158 | -12 | -0.3% | 879,000 |
| 2023/01/30 | 4,159 | 4,183 | 4,152 | 4,170 | -12 | -0.3% | 687,200 |
| 2023/01/27 | 4,218 | 4,218 | 4,169 | 4,182 | -24 | -0.6% | 657,000 |
| 2023/01/26 | 4,242 | 4,256 | 4,201 | 4,206 | -20 | -0.5% | 665,300 |
401～
450
件表示中 / 3412件
類似銘柄と比較する
現在ご覧いただいている「大塚ＨＤ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 大塚ＨＤ | 891,000円 | +14.4% | +120.8% | 1.35% | 20.00倍 | 1.83倍 |
|
国内製薬大手で抗精神病薬が主力。ポカリスエットなど機能性食品も拡大。世界９０カ所に工場 |
| 第一三共 | 443,500円 | +14.3% | +20.1% | 1.35% | 37.27倍 | 5.17倍 |
|
国内製薬大手。循環器と感染症薬強い。英アストラゼネカ社と提携し、がん領域の開拓中 |
| 武 田 | 411,300円 | +5.1% | +76.2% | 4.77% | 95.87倍 | 0.94倍 |
|
国内製薬首位。がん、中枢神経、消化器、希少疾患等に重点。巨額買収で世界売上上位１０強入り |
| アステラス薬 | 156,200円 | +12.2% | +180.3% | 4.74% | 55.93倍 | 1.83倍 |
|
医薬品国内２位。開発技術起点の研究開発体制。前立腺がん薬が柱。遺伝子・細胞治療技術育成 |
| 塩野義 | 209,400円 | +5.7% | +3.9% | 2.74% | 10.42倍 | 1.38倍 |
|
抗ＨＩＶ薬が大型製品に。感染症、疼痛・中枢神経領域に強み。米国に積極展開。欧州、アジア開拓 |
市場注目の銘柄
チャート関連のコラム
